Trial · NCT06268093
The Therapeutic Effect of Thalidomide in Syringomyelia
NCT06268093, Phase 2, Recruiting, Xuanwu Hospital, Beijing
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Therapeutic Effect of Thalidomide in Syringomyelia. Trials, record NCT06268093. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06268093
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Therapeutic Effect of Thalidomide in Syringomyelia
- NCT number
- NCT06268093
- Status
- Recruiting
- Phases
- Phase 2
- Enrollment
- 30 participants, estimated
- Lead sponsor
- Xuanwu Hospital, Beijing
- Conditions
- Syringomyelia, Thalidomide
- Interventions
- Thalidomide
- First posted
- 2024-02-20
- Last updated
- 2024-02-20
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | ASIA Score | 1 day before and 3 days, 3 months after drug treatment | American Spinal Injury Association(ASIA) Score for evaluating the spinal cord function， degree of the spinal cord function, motor1-100, sensory 1-224, higher scores mean a better outcome |
| Secondary | syringomyelia remission | 1 day before and 3 days, 3 months after drug treatment | syringomyelia remission is defined as ≥ 25% reduction in syringomyelia volume on T2 images at week 12, as compared with that before thalidomide usage |
| Secondary | The evoked electromyographic signal (eEMG) potential | 1 day before and 3 days, 3 months after drug treatment | The evoked electromyographic signal (eEMG) potential is the standard index |
| Secondary | Visual Analog Scale (VAS) | 1 day before and 3 days, 3 months after drug treatment | degree of the pain, 1-10, higher scores mean a worse outcome |
| Secondary | Klekamp and Sammi syringomyelia scale | 1 day before and 3 days, 3 months after drug treatment | for evaluating the spinal cord function, higher scores mean a better outcome |
| Secondary | modified Japanese Orthopaedic Association Scores (mJOA) | 1 day before and 3 days, 3 months after drug treatment | Motor function， sensory， bladder function；for evaluating the spinal cord function；0-17， higher scores mean a better outcome |
| Secondary | xuanwu syringomyelia scale | 1 day before and 3 days, 3 months after drug treatment | for evaluating the spinal cord function, for evaluating the spinal cord function；0-18， higher scores mean a worse outcome |
| Secondary | Incidence of complications | 1 day before and 3 days, 3 months after drug treatment | Incidence of complications |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06268093
GET https://conductscience.org/api/trials/v1/NCT06268093/registered